Paul Gaynon, MD
Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation
Professor of Pediatrics, Keck School of Medicine of USC
Education
Medical School
University of Illinois College of Medicine
Internship
Stanford University Program: Pediatrics
Residency
Stanford University Program: Pediatrics
Fellowship
Children's Memorial Hospital/Chicago: Pediatrics Hematology/Oncology
Accomplishments
Certifications
Pediatrics: American Board of Pediatrics; Pediatric Hematology-Oncology: American Board of Pediatrics
Publications
PubMed Link
Research
New Agents and Childhood Acute LyMPHoblastic Leukemia (ALL)
Research Studies
This study is testing a new experimental drug Temisirolimus - Temsirolimus (also known as Torisel®) is approved for kidney cell cancer treatment in adults - in combination with approved chemotherapy drugs - in the hopes of finding a drug combination that may be effective against leukemia and non-hodgkin’s lymphoma that has come back after initial treatment.
